These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10211783)

  • 21. Characterization of phage-displayed recombinant anti-idiotypic antibody fragments against coronavirus-neutralizing monoclonal antibodies.
    Lamarre A; Talbot PJ
    Viral Immunol; 1997; 10(4):175-82. PubMed ID: 9473148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the active site of the placental isozyme of alkaline phosphatase by phage-displayed scFv antibodies selected by a specific uncompetitive inhibitor.
    Saini D; Kala M; Jain V; Sinha S
    BMC Biotechnol; 2005 Dec; 5():33. PubMed ID: 16372914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies.
    Sakai K; Shimizu Y; Chiba T; Matsumoto-Takasaki A; Kusada Y; Zhang W; Nakata M; Kojima N; Toma K; Takayanagi A; Shimizu N; Fujita-Yamaguchi Y
    Biochemistry; 2007 Jan; 46(1):253-62. PubMed ID: 17198396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schistosoma japonicum: construction of phage display antibody library and its application in the immunodiagnosis of infection.
    Chen DX; He A; Zhan XM; Yu MH; Lei ZG; Meng JX; Li ZY; Liang Y; Zhang RL
    Chin Med J (Engl); 2004 Nov; 117(11):1697-703. PubMed ID: 15569489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments.
    Fagète S; Botas-Perez L; Rossito-Borlat I; Adea K; Gueneau F; Ravn U; Rousseau F; Kosco-Vilbois M; Fischer N; Hartley O
    Protein Eng Des Sel; 2017 Sep; 30(9):575-582. PubMed ID: 28444391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
    J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
    Winthrop MD; DeNardo SJ; Albrecht H; Mirick GR; Kroger LA; Lamborn KR; Venclovas C; Colvin ME; Burke PA; DeNardo GL
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.
    Schier R; Bye J; Apell G; McCall A; Adams GP; Malmqvist M; Weiner LM; Marks JD
    J Mol Biol; 1996 Jan; 255(1):28-43. PubMed ID: 8568873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of human nonimmune library and selection of scFvs against IL-33.
    Yuan Q; Huang L; Wang X; Wu Y; Gao Y; Li C; Nian S
    Appl Biochem Biotechnol; 2012 Jun; 167(3):498-509. PubMed ID: 22562552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing human anti crotoxin scFv isolated from a nonimmunized phage library.
    Cardoso DF; Nato F; England P; Ferreira ML; Vaughan TJ; Mota I; Mazie JC; Choumet V; Lafaye P
    Scand J Immunol; 2000 Apr; 51(4):337-44. PubMed ID: 10736105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening of anti-Cry1Ac scFv from A phage display antibody library.].
    Wang Y; Liu Y; Wang X; Qian YP; Liu XJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Dec; 25(12):1146-8. PubMed ID: 19961804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes.
    van Wyngaardt W; Malatji T; Mashau C; Fehrsen J; Jordaan F; Miltiadou D; du Plessis DH
    BMC Biotechnol; 2004 Apr; 4():6. PubMed ID: 15059288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining Yeast Display and Competitive FACS to Select Rare Hapten-Specific Clones from Recombinant Antibody Libraries.
    Sun Y; Ban B; Bradbury A; Ansari GA; Blake DA
    Anal Chem; 2016 Sep; 88(18):9181-9. PubMed ID: 27571429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology.
    Abdolalizadeh J; Nouri M; Zolbanin JM; Barzegari A; Baradaran B; Barar J; Coukos G; Omidi Y
    Curr Pharm Des; 2013; 19(15):2839-47. PubMed ID: 23432628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of tumor-specific internalizing human antibodies from phage libraries.
    Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD
    J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.
    Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y
    Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Novel System for Discovering High-affinity Antibody Mutants That Enables Immunoassays with Higher Sensitivities -Development and Application of Clonal Array Profiling (CAP)].
    Kiguchi Y
    Yakugaku Zasshi; 2022; 142(11):1153-1159. PubMed ID: 36328444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.
    Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI
    Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.